Orthocell (OCC) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period StockTake: Orthocell to enter the US marketApril 23 at 9:56 PM | msn.comOrthocell sees US Remplir sales on immediate horizon as distro deal locked inApril 23 at 9:56 PM | msn.comOrthocell Expands into US Nerve Repair Market with New DistributorsApril 22, 2025 | tipranks.comHealth Check: Drug sector panic sets in at the prospect of a Trump tariff ‘pharma-geddon’April 9, 2025 | msn.comOrthocell Gains ANVISA Approval for Striate+ in Brazil, Expanding Latin American ReachApril 8, 2025 | tipranks.comLong Shortz with Orthocell: Remplir gets FDA green lightApril 8, 2025 | msn.comHealth Check: We’re ‘duty free’, declare several ASX life science companiesApril 7, 2025 | msn.comScott Power: ASX health stocks fall but… Orthocell nails its US FDA approvalApril 5, 2025 | msn.comLunch Wrap: Tariff storm sinks ASX again, but Orthocell powers ahead with FDA approvalApril 4, 2025 | msn.comLevel achieved: Orthocell gains FDA approval for flagship nerve repair productApril 4, 2025 | msn.comThis company has entered a trading halt, is it about to announce FDA approval?April 3, 2025 | msn.comOrthocell Secures US FDA Clearance for Remplir Nerve Repair ProductApril 3, 2025 | tipranks.comOrthocell Limited Requests Trading Halt Pending FDA Clearance AnnouncementApril 2, 2025 | tipranks.comOrthocell to Present at HealthInvest 2025, Updates on FDA ApplicationApril 1, 2025 | tipranks.comStockTake: Another country under the beltMarch 26, 2025 | msn.comHealth Check: Fantastico! Telix wins Brazilian assent for prostate cancer imaging agentMarch 18, 2025 | msn.comBreak it Down: Orthocell’s Striate+ gets green light in Lion CityMarch 18, 2025 | msn.comUp 290% in 12 months: Why this ASX healthcare stock is surging again todayMarch 17, 2025 | msn.comOrthocell Secures Singapore Regulatory Approval for Striate+March 17, 2025 | tipranks.comOrthocell shares up 10% today; anticipates FDA approval in the coming weeksMarch 17, 2025 | msn.comHere's Why We're Not Too Worried About Orthocell's (ASX:OCC) Cash Burn SituationFebruary 27, 2025 | finance.yahoo.comOrthocell Accelerates Global Expansion with U.S. Market EntryFebruary 24, 2025 | tipranks.comOrthocell Limited Reports Improved Financial Results for Half-Year 2024February 24, 2025 | tipranks.comOrthocell Expands Global Reach with Thai FDA Application for Remplir™February 20, 2025 | tipranks.comBiocurious: Hut Hut Hut! The growing list of ASX biotechs waiting for the FDA to call the start of playFebruary 11, 2025 | msn.comOrthocell continues global expansion with eyes on US$75 million a year Canadian marketFebruary 2, 2025 | proactiveinvestors.comOrthocell soars 14% after crushing early sales growth for RemplirJanuary 22, 2025 | msn.comHealth Check: We’ll see you in court and you bladder believe it, says Pacific Edge after unfavourable US rulingJanuary 21, 2025 | msn.comOrthocell Limited Accelerates Global Expansion for Remplir™January 21, 2025 | tipranks.comOrthocell Secures $3.18 Million R&D Tax Incentive BoostJanuary 19, 2025 | tipranks.comOrthocell Issues 3 Million Unquoted OptionsJanuary 14, 2025 | tipranks.comFIVE at FIVE AU: Aussie share market up as underlying inflation starts to coolJanuary 8, 2025 | au.investing.comOrthocell continues on growth path with third consecutive quarter of record revenueJanuary 7, 2025 | au.investing.comOrthocell achieves third consecutive quarter of record revenueJanuary 7, 2025 | msn.comOrthocell Limited Reports Third Consecutive Quarter of Record RevenueJanuary 7, 2025 | tipranks.comThose who invested in Orthocell (ASX:OCC) a year ago are up 235%December 31, 2024 | finance.yahoo.comChartWatch ASX Scans: Iondrive, Orthocell, Perenti, Mesoblast, Singular Health, Lifestyle Communities, Woodside Energy, Whitehaven CoalDecember 20, 2024 | msn.comOrthocell files FDA application to sell nerve-repair product in the USDecember 19, 2024 | msn.comHealth Check: Joy as Mesoblast wins its first FDA approval for a stem-cell therapy after decades of tryingDecember 18, 2024 | msn.comASX Market Close: Index dives to three week low | December 12, 2024December 12, 2024 | msn.comOrthocell passes commercialisation milestone with first Remplir™ sales in SingaporeDecember 12, 2024 | au.investing.comFirst sales in Singapore for Orthocell’s nerve-repair product RemplirDecember 12, 2024 | msn.comBreak it Down: Orthocell’s pivotal path into US healthcare marketDecember 3, 2024 | msn.comOrthocell leaps closer to FDA approval after pivotal nerve-repair product study successDecember 3, 2024 | msn.comHealth Check: No sign of frayed nerves as Orthocell girds for US approvalDecember 3, 2024 | msn.comOrthocell spikes 7% after clearing huge US hurdle for its nerve repair productDecember 3, 2024 | msn.comBreaking Out: Regenerative medicine play Orthocell’s run might just be getting startedNovember 29, 2024 | msn.comBreak it Down: Orthocell takes next leap into Singapore salesNovember 27, 2024 | msn.comLong Shortz with Orthocell: No nerves as company enters US marketNovember 13, 2024 | msn.comOrthocell prepares for Remplir™ commercialisation in US with two executive appointmentsNovember 11, 2024 | au.investing.com Get Orthocell News Delivered to You Automatically Sign up to receive the latest news and ratings for OCC and its competitors with MarketBeat's FREE daily newsletter. Email Address OCC Media Mentions By Week OCC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCC News Sentiment▼-0.031.03▲Average Medical News Sentiment OCC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCC Articles This Week▼31▲OCC Articles Average Week Get Orthocell News Delivered to You Automatically Sign up to receive the latest news and ratings for OCC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Worthington Steel News Today Constellium News Today Algoma Steel Group News Today Steel Partners News Today Metallus News Today United States Antimony News Today Webco Industries News Today Ascent Industries News Today Friedman Industries News Today Crystal Amber News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:OCC) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthocell Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Orthocell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OCC Stock Free OCC Stock Alerts